Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

2.490
-0.050-1.97%
Volume:379.52K
Turnover:934.27K
Market Cap:1.54B
PE:-6.86
High:2.560
Open:2.560
Low:2.390
Close:2.540
52wk High:5.830
52wk Low:2.300
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:2.87
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.363
ROE:-242.61%
ROA:-17.94%
PB:-9.50
PE(LYR):-6.86
PS:- -

Loading ...

Guosen Securities Identifies Opportunities in CXO and Medical Device Sectors, Highlights Innovative Drug Supply Chain and Undervalued Segments

Stock News
·
Mar 17

HK Movers | Biotech Stocks Jump. Wuxi XDC up 7%; Junshi Bio up 6%; Remegen, Genscript Bio, Wuxi Apptec up around 5%; Innocare up over 4%.

Tiger Newspress
·
Mar 17

Overseas Expansion Momentum and Policy Backing Propel Hong Kong Connect Innovative Drug Stocks Higher in Afternoon Session

Deep News
·
Mar 16

Hong Kong Stock Connect Biotech Sector Faces Continued Downturn: Has It Bottomed Out?

Deep News
·
Mar 15

Has the Sector Bottomed Out? Huabao Fund's Hong Kong Connect Innovative Drug ETF (520880) Marks Third Consecutive Weekly Decline

Deep News
·
Mar 13

Hengrui Pharma's Innovative Drug Hetrombopag Olamine Tablets Gain Additional Indication

Stock News
·
Mar 13

Haisco Secures IND Application Acceptance for Innovative Drug HSK44459 Cream in Two Indications

Stock News
·
Mar 12

Enhanced and Comprehensive: HUABAO Fund's HK Stock Connect Innovative Drug ETF Rebalances, Swiftly Includes Newly Eligible Stocks for Full Coverage of 50 R&D Firms

Deep News
·
Mar 12

Hunan Nucien Pharmaceutical's Flu Drug Revenue Plummets, Faces Losses After Failed Acquisition

Deep News
·
Mar 11

港股通生物科技板块迎来流动性与基本面双重提振 南方基金叶震南:回调后低位配置价值显现

Deep News
·
Mar 11

Overseas Capital Quietly Accumulates Biotech ETFs: What's Driving the Move?

Deep News
·
Mar 11

China Galaxy Securities: Provincial-Level Health Insurance Pooling Could Mark New Starting Point for Long-Term Healthcare Investments

Stock News
·
Mar 11

Policy Boosts Commercial Health Insurance: Breaking Barriers in Innovative Drug Payment

Deep News
·
Mar 11

Global Pharma Giants' 2025 Report Card: A New "Drug King" Emerges, Innovative Asset Deals Hit Record High

Deep News
·
Mar 11

IMMUNOTECH-B (06978.HK) Schedules 20 Mar 2026 Board Meeting to Approve FY2025 Annual Results

Bulletin Express
·
Mar 10

Immunotech Biopharm schedules board meeting to approve annual results

Reuters
·
Mar 10

Beijing Hotgen Biotech's Subsidiary Completes First Patient Dosing in Phase II Trial for Innovative Drug SGC001

Stock News
·
Mar 10

Innovative Drug Stocks Rebound with Salubris Pharmaceuticals Hitting Limit-Up

Deep News
·
Mar 10

Major Portfolio Rebalancing Takes Effect: Huabao Fund's HK Stock Connect Innovative Drug ETF (520880) Adds 13 New Constituents

Deep News
·
Mar 09

How Patients Benefit from High-Cost Drugs Covered by Commercial Insurance: Overcoming the Final Hurdles for Innovative Medicines

Deep News
·
Mar 09